Pro Medicus Limited Statistics
Want to see AU:PME full AI Analyst Report?
Pro Medicus Limited (PME) Stock Statistics & Valuation Metrics
Total Valuation
Pro Medicus Limited has a market cap or net worth of AUD 21.16B. The enterprise value is AUD 21.04B.
- Market Cap
- AUD 21.16B
- Enterprise Value
- AUD 21.04B
Share Statistics
Pro Medicus Limited has 104,469,960 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 104,469,960
- Owned by Insiders
- 46.92%
- Owned by Institutions
- 8.80%
Financial Efficiency
Pro Medicus Limited’s return on equity (ROE) is 0.59 and return on invested capital (ROIC) is 24.67%.
- Return on Equity (ROE)
- 0.59
- Return on Assets (ROA)
- 0.43
- Return on Invested Capital (ROIC)
- 24.67%
- Return on Capital Employed (ROCE)
- 0.35
- Revenue Per Employee
- 1.71M
- Profits Per Employee
- 1.73M
- Employee Count
- 153
- Asset Turnover
- 0.43
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Pro Medicus Limited is 80.63. Pro Medicus Limited’s PEG ratio is 0.63.
- PE Ratio
- 80.63
- PS Ratio
- 81.76
- PB Ratio
- 47.45
- Price to FCF
- 180.09
- Price to Operating Cash Flow
- 167.82
- PEG Ratio
- 0.63
Income Statement
In the last 12 months, Pro Medicus Limited had revenue of 261.69M and earned 265.34M in profits. Earnings per share was 2.54.
- Revenue
- 261.69M
- Gross Profit
- 211.15M
- Operating Income
- 196.12M
- Pretax Income
- 377.52M
- Net Income
- 265.34M
- EBITDA
- 204.18M
- Earnings Per Share (EPS)
- 2.54
Cash Flow
In the last 12 months, operating cash flow was 127.48M and capital expenditures -8.69M, giving a free cash flow of 118.80M billion.
- Operating Cash Flow
- 127.48M
- Free Cash Flow
- 118.80M
- Free Cash Flow per Share
- 1.14
Dividends & Yields
Pro Medicus Limited pays an annual dividend of AUD 0.32, resulting in a dividend yield of 0.34%
- Dividend Per Share
- AUD 0.32
- Dividend Yield
- 0.34%
- Payout Ratio
- 27.65%
- Free Cash Flow Yield
- 0.56%
- Earnings Yield
- 1.25%
Stock Price Statistics
- Beta
- 1.32
- 52-Week Price Change
- -20.71%
- 50-Day Moving Average
- 177.33
- 200-Day Moving Average
- 158.88
- Relative Strength Index (RSI)
- 62.80
- Average Volume (3m)
- 218.19K
Important Dates
Pro Medicus Limited upcoming earnings date is Feb 16, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Aug 17, 2026
- Next Earnings Date
- Feb 16, 2027
- Ex-Dividend Date
- Feb 25, 2026
Financial Position
Pro Medicus Limited as a current ratio of 6.82, with Debt / Equity ratio of 0.49%
- Current Ratio
- 6.82
- Quick Ratio
- 6.82
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- -0.71
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Pro Medicus Limited has paid 112.17M in taxes.
- Income Tax
- 112.17M
- Effective Tax Rate
- 0.30
Enterprise Valuation
Pro Medicus Limited EV to EBITDA ratio is 102.94, with an EV/FCF ratio of 176.92.
- EV to Sales
- 80.32
- EV to EBITDA
- 102.94
- EV to Free Cash Flow
- 176.92
- EV to Operating Cash Flow
- 164.87
Balance Sheet
Pro Medicus Limited has AUD 250.62M in cash and marketable securities with AUD 2.23M in debt, giving a net cash position of AUD 248.39M billion.
- Cash & Marketable Securities
- AUD 250.62M
- Total Debt
- AUD 2.23M
- Net Cash
- AUD 248.39M
- Net Cash Per Share
- AUD 2.38
- Tangible Book Value Per Share
- AUD 4.10
Margins
Gross margin is 80.69%, with operating margin of 74.94%, and net profit margin of 101.40%.
- Gross Margin
- 80.69%
- Operating Margin
- 74.94%
- Pretax Margin
- 144.26%
- Net Profit Margin
- 101.40%
- EBITDA Margin
- 78.02%
- EBIT Margin
- 74.94%
Analyst Forecast
The average price target for Pro Medicus Limited is AUD 219.27, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
- Price Target
- AUD 219.27
- Price Target Upside
- 8.24% Upside
- Analyst Consensus
- Moderate Buy
- Analyst Count
- 9
- Revenue Growth Forecast
- 22.87%
- EPS Growth Forecast
- 130.30%
Scores
- Smart Score
- 8
- AI Score
- 71

